Head & Neck
Advanced:
IRB #H-26649: Feasibility and Outcome of CyberKnife Stereotactic Radiosurgical Boost and Salvage Therapy for Head and Neck Cancer
CIRB #H-29284/RTOG #R0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab For Locally-Advanced Resected Head and Neck Cancer
High Risk:
IRB# pend/RTOG #R1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck (Not yet submitted to IRB)
Salivary Gland Tumors:
IRB #H-32124/RTOG# R1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Symptom Management:
IRB #H-32159/MDA 04-01 : A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer (Pending IRB approval)
IRB #H-26283: Phase III, Randomized, Controlled, Mulit-Center Clinical Trial Evaluating the Efficacy of Electrical Stimulation for Dysphagia in Head and Neck Cancer Patients (contact Gintas @ 4-1756)
